Therefore, any transcriptional, translational, or migratory changes seen in the Ewing sarcoma cells treated with exogenous recombinant Wnt5a result from activation of a beta-catenin-independent Wnt signaling pathway. This evidence concerns the gene CTNNB1 and Ewing sarcoma.